Pharmaceutical Analysis

This virtual forum discusses the risk assessment and analytical challenges of detection and quantification of trace level impurities in pharmaceutical products including mutagenic nitrosamine impurities.

Analysis of nitrosamines in pharmaceutical products presents certain unique challenges in terms of interferences, elevated baselines, inconsistencies in quantifications and decreasing method performance. Most of these challenges can be addressed by...

Separation Science met with Agilent experts to discuss root causes for the presence of nitrosamines in drug substances and drug products, the current regulatory guidance to help identify these mutagenic impurities, the key analytical strategies that...

Separation Science, in collaboration with Agilent, offers a technology guide that provides key information for individuals looking to improve knowledge and analytical skills in the trace analysis of nitrosamines in pharmaceutical products. From...